AI Article Synopsis

  • Primary hepatic rhabdomyosarcoma is a rare condition, creating challenges in deciding treatment options like surgery and radiation.
  • A pediatric case is presented where a patient received yttrium-90 (Y-90) microspheres followed by external beam radiation therapy (EBRT) interspersed with chemotherapy, showing a significant treatment response and minimal side effects.
  • After 23 months, the patient experienced disease recurrence, highlighting the need for ongoing local and systemic therapies for effective tumor control.

Article Abstract

Primary hepatic rhabdomyosarcoma is rare, making decisions regarding locoregional management with resection and/or conventional radiation difficult. We present a novel treatment approach for a pediatric patient diagnosed with rhabdomyosarcoma diffusely involving the liver. This patient underwent treatment with yttrium-90 (Y-90) microspheres followed by external beam radiation therapy (EBRT ) to residual disease, interdigitated with systemic chemotherapy. Initial post-radiation imaging showed significant response to treatment, and she experienced minimal acute toxicities and no long-term toxicities. She developed recurrent PET-avid disease 23 months after Y-90 treatment, necessitating further local and continued systemic therapies. We report on the tumor control following Y-90 and EBRT treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149128PMC
http://dx.doi.org/10.5603/RPOR.a2021.0008DOI Listing

Publication Analysis

Top Keywords

treatment approach
8
approach pediatric
8
pediatric patient
8
treatment
6
potential alternative
4
alternative treatment
4
patient diffusely
4
diffusely infiltrative
4
infiltrative primary
4
primary rhabdomyosarcoma
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!